系统性红斑狼患者死亡率的时间趋势:丹麦基于人口的匹配队列研究
Salome Kristensen1,2, Kirsten Duch1, Bolette Gylden Soussi1,3
1Department of Rheumatology, Center of Rheumatic Research Aalborg, Aalborg University Hospital, Aalborg, Denmark.
Rheumatology (Oxford, England)
|April 24, 2024
概括
系统性红斑狼 (SLE) 患者的死亡风险随着时间的推移而降低,但5年死亡率仍然存在. 对于年轻的SLE患者来说,长期存活仍然是一个问题,需要继续关注疾病管理和并发症预防.
科学领域:
- 类风湿病学 类风湿病学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 与一般人群相比,全身性红斑狼 (SLE) 与死亡率的增加有关.
- 了解SLE死亡率的时间趋势对于评估医疗保健进步和患者结果至关重要.
研究的目的:
- 研究SLE患者与近几十年一般人口相比的5年和10年全因死亡率.
- 分析随着时间的推移与SLE相关的死亡率的趋势,并确定风险因素.
主要方法:
- 一项丹麦全国范围的基于人口的队列研究,利用行政卫生登记册.
- 事件SLE病例 (1996-2015年) 与对照病例相匹配1:5,并跟踪到2020年.
- 使用伪观测方法进行了时间到事件的分析.
主要成果:
- 在研究期间,SLE患者的原始5年死亡风险差异 (RD) 从10.3%降至4.6%.
- 5年死亡率的相对风险 (RR) 也下降,随着伴随性疾病调整后的趋势持续下去.
- 10年死亡率 (RR) 没有随着时间的推移而变化,在年轻的SLE患者 (<50岁) 中最高.
结论:
- 虽然SLE患者的5年死亡风险有所降低,但过度死亡率仍然存在,特别是在最近的时期和疾病的晚期.
- 10年死亡风险没有改善,对于患有SLE的年轻人来说仍然很高.
- 预防疾病进展和管理并发症的持续努力对于改善SLE患者的长期结果至关重要.
相关概念视频
Introduction To Survival Analysis
221
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
221
Assumptions of Survival Analysis
125
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
125
Actuarial Approach
77
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
77
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Comparing the Survival Analysis of Two or More Groups
178
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
178


